-
1 Comment
Tibet AIM Pharm. Inc is currently in a long term downtrend where the price is trading 6.3% below its 200 day moving average.
From a valuation standpoint, the stock is 73.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.6.
Tibet AIM Pharm. Inc's total revenue rose by 31.2% to $155M since the same quarter in the previous year.
Its net income has increased by 6.1% to $4M since the same quarter in the previous year.
Finally, its free cash flow grew by 119.0% to $17M since the same quarter in the previous year.
Based on the above factors, Tibet AIM Pharm. Inc gets an overall score of 4/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE100002C39 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Beta | 0.27 |
|---|---|
| Market Cap | 2B |
| PE Ratio | 61.41 |
| Target Price | 12 |
| Dividend Yield | 0.3% |
Tibet AIM Pharm. Inc. engages in the research and development, manufacturing, and sale of medical products in China. The company's products include Miglitol tablets for diabetes; Gualoupi injection for coronary disease; Oxytocin injection for gynecology and obstetrics; and NalMefene injection for various acute poisoning, such as alcohol, organic phosphor, CO, sedative-hypnotic, opioid substance, serious infection, shock, fainting, and brain, as well as coma, spinal cord injury, cerebral infarction, hemorrhage, etc. It also provides Carbetocin injections for prevention of postpartum hemorrhage; Domperidone tablets for treatment of indigestion, abdominal bloating, belching, nausea, vomiting, and abdominal distension and pain; Montmorillonite powder for chronic diarrhea; Hongjin Xiaojie tablets and Aceclofenac Enteric-Coated tablets, as well as for the treatment of antibiotics, antiallergic, and digestive systems. Tibet AIM Pharm. Inc. was founded in 2003 and is headquartered in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002826.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
